Å·ÃÀAV

Introduction

The Å·ÃÀAV Biotechnology Group and sponsors invite you to a one day conference focused on solving the mechanisms involved in neurological disorders that will facilitate the discovery of disease - modifying treatments. This conference , which is the third in the series, brings together the top influential academic and industrial researchers in the field and will be of interest to all scientific disciplines involved in neuroscience. The Å·ÃÀAV Biotechnology Group invites your attendance at this comprehensive meeting where the latest developments in this challenging area of neuroscience will be presented.

Deadlines

• Apr 11 2016
  Poster abstract deadline

  
• Apr 16 2016
  Standard registration deadline

  

Useful links

Speakers

• Dr Eric Karran Alzheimer's Research, United Kingdom
• Professor John Hardy University College London, United Kingdom
• Dr Kristian Stromgaard University of Copenhagen, Denmark
• Dr Andrew Thomas Roche Innovation Centre, Switzerland
• Professor Nigel Hooper University of Manchester, United Kingdom
• Dr Richard Mead University of Sheffield, United Kingdom
• Professor Simon Ward University of Sussex, United Kingdom
• Dr Suchira Bose Eli LIlly, United Kingdom

---

Sponsorship & supporting organisations

To be confirmed

Venue

The Å·ÃÀAV

Conference Room, The Å·ÃÀAV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee

• Dr Irene Francois Å·ÃÀAV Biotechnology Group, United Kingdom
• Professor Joe Sweeney Å·ÃÀAV Biotechnology Group, United Kingdom
• Mr Neville Nicholson Å·ÃÀAV Biotechnology Group, United Kingdom

---

Organised by

The Å·ÃÀAV Biotechnology Group

Contact information

Doctor Irene Francois
Freelance Consultant Drug Discovery
Furze Field Lodge
Woodlands
Send
Surrey GU23 7LD
+44(0)1483469599
Contact us by email

---